Vivo Capital’s AtriCure ATRC Stock Holding History

Vivo Capital’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-64,573	Closed	-$4.23M	–	61
2021 Q1	$4.23M	Hold	64,573	–	–	0.15%	54
2020 Q4	$3.6M	Hold	64,573	–	–	0.16%	51
2020 Q3	$2.58M	Hold	64,573	–	–	0.15%	59
2020 Q2	$2.9M	Hold	64,573	–	–	0.21%	50
2020 Q1	$2.17M	Buy	+64,573	New	+$2.32M	0.2%	47

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Vivo Capital's ATRC Position: Q2 2021 in Review

Vivo Capital sold out of AtriCure (ATRC) in Q2 2021, closing a stake of 64,573 shares — an estimated $4.23M sold.

Vivo Capital first reported a position in ATRC in Q1 2020 and held it in 5 quarters. The position peaked at $4.23M in Q1 2021. 212 funds tracked by Wall St. Rank hold ATRC as of Q2 2021.

Vivo Capital reported no remaining AtriCure position as of Q2 2021 after selling out during the quarter.
Vivo Capital sold 64,573 AtriCure shares in Q2 2021, an estimated $4.23M.
Vivo Capital first reported a position in AtriCure in Q1 2020 and held it in 5 quarters.
Vivo Capital's AtriCure position peaked at $4.23M in Q1 2021.
212 funds tracked by Wall St. Rank held AtriCure as of Q2 2021.

Based on Vivo Capital's 13F filing for Q2 2021, filed 16 Aug 2021.